• Journal of Dairy Science and Biotechnology
• /
• 제31권1호
• /
• pp.1-7
• /
• 2013

Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the prevention and treatment of pathologic conditions when they are ingested. Although there is a relatively large volume of literature that supports the use of probiotics to prevent or treat intestinal disorders, the scientific basis behind probiotic use has only recently been established, and clinical studies on this topic are just beginning to get published. Currently, the best studied probiotics are lactic acid bacteria, particularly Lactobacillus and Bifidobacterium species. Other organisms used as probiotics in humans include Escherichia coli, Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., Propionibacterium sp., and various fungi, and some probiotic preparations contain more than one bacterial strain. Probiotic use for the prevention and treatment of antibiotic-associated diarrhea caused by Clostridium difficile induced intestinal disease as well as for other gastrointestinal disorders has been discussed in this review.

• 한국유가공학회:학술대회논문집
• /
• 한국유가공기술과학회 2004년도 제58회 춘계유가공심포지움 - 세계 우유의 날 기념 국제 심포지움
• /
• pp.21-39
• /
• 2004

Fermented milks have been recognized as healthy foods since ancient times, but those using intestinal bacteria such as Bifidobacterium and lactic acid bacteria (LAB) are even more valuable from the standpoint of view of maintaining health. They have also now come to be recognized as important in the field of preventive medicine. Although advances in the medical sciences in the last 50 years have significantly increased the human lift span, an unfortunate fact is that many of us are now living long enough to experience chronic disorders such as coronary heart disease, hypertension, osteoporosis, diabetes and cancer. In recent years there has been renewed interest in health promotion and disease prevention by incorporating probiotic bacteria into foods to counteract harmful bacteria in the intestinal tract. Therefore, there are now a wide variety of commercial products containing prospective probiotics that claim health-promoting effects, such reductions in large botvel carcinogens and mutagens, antitumor properties, cholesterol-lowering effects, increased lactose digestion, relief from con-stipation, stimulation of immunocomponent cells and enhancement of phagocytosis. Two well-known representative probiotic is LAB and Bifidobaclerium. Traditional probiotic dairy strains of LAB which have been designated as GRAS (Generally Recognized As Safe) bacteria have a long history of safe use and most strains are considered comestible microorganisms with no pathogenic potential. Accordingly, there is considerable interest in extending the range of foods containing probiotic organisms from dairy foods to infant formulas, baby foods, and pharmaceuticals. In addition, the ingestion of probiotics, prebiotics, and symbiotic as wll as combinations of pro- and prebiotics has recently aroused renewed interest as enhancing the beneficial relationship between the host and intestinal microflora in both healthy and diseased indivisuals. Non-communicable chronic diseases such as cancer, cerebral hemorrhage, is chemic heart disease, and diabetes mellitus has recently been recognized as adult diseases in Japan as well as other countries. and are considered to be inevitably associated with aging. These diseases occur as a result of individual life styles. The Japanes Government. Ministry of Health, Labor and Welfare has proposed substituting the term 'adult diseases' with 'lifestyle-related diseases'. It has emphasized the importance of prevention rather than treatment. since the well-known increase in the elderly population in Japan is predicted to result in a variety of socioeconomic problems. n this lecture on the Present status of fermented milk products in Japan, I will report a strategy for the development of fermented milk products in Japan from the standpoint of view of research in Japan on LAB and Bifidobacteria. They could play an important role in preserving human health by controlling intestinal microflora capable of producing toxic effects on the host.

• 한국식품과학회지
• /
• 제25권2호
• /
• pp.89-93
• /
• 1993

한국인의 분변으로부터 분리된 Bifidobacterium sp. Int-57은 다른 장내세균에 비해 ${\beta}-xylosidase$의 높은 역가를 보였으며, xylooligomer의 bifidogenic factor의 유용성을 고려하였을 때 효소생산에 초점을 둔 결과 최적 탄소원으로는 xylose였는데, 일반적으로 최종생산물은 feedback inhibition, feedback repression 등으로 효소 생산을 억제하는 일반 이론과는 상이한 결과를 보였다. 또한 xylose는 1.1%일 때 가장 높은 효소역가를 보였다. 질소원으로서는 yeast extract였고, 그 농도가 0.04%일 때, 무기염류 면에서는 $CoCl_2$였고, 농도가 0.0003%일 때 ${\beta}-xylosidase$의 최대 생산을 보였다.

• IMMUNE NETWORK
• /
• 제14권2호
• /
• pp.100-106
• /
• 2014

Infection with invasive Shigella species results in intestinal inflammation in humans but no symptoms in adult mice. To investigate why adult mice are resistant to invasive shigellae, 6~8-week-old mice were infected orally with S. flexneri 5a. Shigellae successfully colonized the small and large intestines. Mild cell death was seen but no inflammation. The infected bacteria were cleared 24 hours later. Microarray analysis of infected intestinal tissue showed that several genes that are involved with the sphingosine-1-phosphate (S1P) signaling pathway, a lipid mediator which mediates immune responses, were altered significantly. Shigella infection of a human intestinal cell line modulated host S1P-related genes to reduce S1P levels. In addition, co-administration of S1P with shigellae could induce inflammatory responses in the gut. Here we propose that Shigella species have evasion mechanisms that dampen host inflammatory responses by lowering host S1P levels in the gut of adult mice.

• 한국식품영양학회지
• /
• 제1권1호
• /
• pp.33-40
• /
• 1988

A Study was conducted to investigate the effect of feeding Lactobacillus casei YS on the growing performance and gastrointestinal flora of the suckling piglets, which were delivered from 2 heads of three-way crossbred(Landrace$\times$Large White$\times$Duroc) pigs, for 4 weeks. The results from the present study was summarized as follows. Average body weight gains of feeding group was slightly better than that of control group and diarrhea was prevented by successive 7 days feeding. Population levels of lactic acid bacteria were maintained about 107 colony forming unit(cfu) per gram of the contents in both feeding and control group at upper parts of small intestine. In this part, coliform count was greatly reduced in (ceding group but not in control group. pH values of the intestinal contents were gradually decreased especially at the upper part of alimentary track of feeding group. Among lactic acid bacteria, L. salivarius, L. cases and L. fermentum were found most predominant strains in feeding group, Wheareas L. salivarius, L. acidophilus and L. cunts in control group. In the other hand, Escherichia coli recovered from scouring pigs were resistant to the drug such as streptomycin, ampicillin and sensitive to gentamycin and neomycin in vitro test.

• Animal Bioscience
• /
• 제36권1호
• /
• pp.63-74
• /
• 2023

Objective: The objective of this study was to investigate the effects of feeding active dry yeast (ADY) and yeast culture (YC) on fecal bacterial community in finishing bulls fed high-concentrate diets in the same experimental environment. Methods: Forty-five healthy finishing cattle (Simmental×Chinese Luxi yellow bulls; 24 months; 505±29 kg) were randomly divided into three groups: i) CON group (control group, only fed basal diet), ii) ADY group (fed basal diet + active dry yeast), and iii) YC group (fed basal diet + yeast culture). At the end of the trial, nine rectum fecal samples were randomly selected from each group for bacterial DNA sequencing. Results: There was no difference among groups about alpha diversity indices (all p>0.05), including ACE, Chao 1, Shannon, and Simpson indices. Principal component analysis and non-metric multidimensional scaling analysis showed a high similarity among three groups. Compared with CON group, ADY and YC groups had greater relative abundance of c_Clostridia, o_Oscillospirales, and f_Oscillospiraceae, but lesser relative abundance of g_Megasphaera, and s_Megasphaera_elsdenii (all p<0.01). And, the relative abundances of p_Firmicutes (p = 0.03), s_Prevotella_sp (p = 0.03), o_Clostridiales (p<0.01), g_Clostridium (p<0.01), f_Caloramatoraceae (p<0.01), and f_Ruminococcaceae (p = 0.04) were increased in the ADY group. The PICRUSt2 prediction results showed that the metabolic pathways had no significant differences among groups (p>0.05). Besides, the relative abundance of c_Clostridia (r = 0.42), and f_Oscillospiraceae (r = 0.40) were positively correlated to average daily gain of finishing bulls (p<0.05). Conclusion: Both of ADY and YC had no effect on diversity of fecal bacteria in finishing bulls, but the supplementation of ADY and YC can improve the large intestinal function in finishing bulls by increasing the abundance of cellulolytic bacteria and altering the abundance of lactic acid-utilizing bacteria.

• 한국식품과학회지
• /
• 제26권3호
• /
• pp.295-299
• /
• 1994

Bacteroides는 대장의 상재균총 중 가장 많이 존재하는 균이다. 본 연구에서는 Bacteroides를 분리하여 동정하고 이들 균주들에 대하여 BL배지와 EG배지를 기본 배지로 하여 항생제 및 대사저해제에 대한 감수성 조사를 한 결과 vancomycin은 Bacteroides와 대장균 이외의 장내균들의 생육을 저해하는 것으로 나타났다. 성인에서 대장균은 Bacteroides에 비하여 숫적으로 훨씬 적게 존재하기 때문에 vancomycin이 첨가된 VA배지를 선택배지로 조제하여 한국인을 대상으로 기존의 NBGT 선택배지와 비교한 결과 선택성이 거의 동일한 것으로 나타났고 유아의 경우에는 VA배지가 NBGT보다 우수하였다.

• 식품과학과 산업
• /
• 제51권1호
• /
• pp.72-80
• /
• 2018

Yogurt, which has long been consumed as a longevity food, is characterized by a large number of lactic acid bacteria. The sales of yogurt market have increased for the past three years due to research findings that the intestinal microbial environment is closely associated with many human diseases and the well-being trend of recent consumers. The recent trends in the yogurt market have focused to low sugar content, functionalities such as enhanced immunity, and yogurt for freezing. In addition, recent yogurt products tend to be labeled for certain lactic acid bacteria having functionality in their products. Many yogurts have names of specific lactic acid bacteria on their products, such as 'Activia' and 'Bifidus'. We monitored the 'Bifidus' products in the market for reflecting its regulated counting in their products required to contain more than 10 million Bifidobacteria according to the revised lactic acid bacteria-counting test of Food Code 2015.

• 한국식품과학회지
• /
• 제27권4호
• /
• pp.598-604
• /
• 1995

원지, 양파 및 쑥을 추출물, 즙 또는 분말로 하여 기준식이에 5 및 10% 첨가하여 흰쥐에게 14일간 먹여 대장내용물에서 주요균의 변화와 ${\beta}-glucosidase$와 ${\beta}-glucuronidase$의 효소활성 및 인돌과 volatile basic nitrogen의 생성량을 조사하였다. 실험쥐들의 사료섭취량과 체중증가량은 쑥의 물추출물 5% 섭취구를 비롯하여 시료 첨가구들에서 대체로 높았으나, 원지물추출물 5%와 쑥의 에탄올추출물 10% 섭취구에서는 체중이 감소하였다. 쑥의 물 또는 에탄올추출물 첨가구에서 유익균인 bifidobacteria가 대조구에 비해 높았고, clostridia와 E. coli는 낮았다(p<0.05). 그외 양파즙 10% 첨가구에서도 유익균의 증가와 유해균의 감소와 같은 유리한 균총변화를 보였다. 한편 쑥분말 5% 첨가구에서 대장내용물중 ${\beta}-glucosidase$와 ${\beta}-glucuronidase$ 활성은 대조구와 비교해 통계적인 유의성이 없으나, 인돌함랑과 pH는 대조구에 비해 낮았다(p<0.05). 그러나 원지물추출물과 양파를 10% 첨가구에서는 ${\beta}-glucosidase$ 활성이, 쑥추출물들의 첨가구에서는 ${\beta}-glucuronidase$ 활성이 높았다(p<0.05). 인돌함량은 단백질 함량이 높은 원지물추출물과 쑥에탄올추출물 첨가구에서 높았다(p<0.05). 한편 휘발성 염기태 질소화합물의 함량은 처리구들에서 유의적인 차이가 없었다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제26권6호
• /
• pp.856-863
• /
• 2013

An in vitro gas production technique was used in this study to elucidate the effect of two strains of active live yeast on methane ($CH_4$) production in the large intestinal content of pigs to provide an insight to whether active live yeast could suppress $CH_4$ production in the hindgut of pigs. Treatments used in this study include blank (no substrate and no live yeast cells), control (no live yeast cells) and yeast (YST) supplementation groups (supplemented with live yeast cells, YST1 or YST2). The yeast cultures contained $1.8{\times}10^{10}$ cells per g, which were added at the rates of 0.2 mg and 0.4 mg per ml of the fermented inoculum. Large intestinal contents were collected from 2 Duroc${\times}$Landrace${\times}$Yorkshire pigs, mixed with a phosphate buffer (1:2), and incubated anaerobically at $39^{\circ}C$ for 24 h using 500 mg substrate (dry matter (DM) basis). Total gas and $CH_4$ production decreased (p<0.05) with supplementation of yeast. The methane production reduction potential (MRP) was calculated by assuming net methane concentration for the control as 100%. The MRP of yeast 2 was more than 25%. Compared with the control group, in vitro DM digestibility (IVDMD) and total volatile fatty acids (VFA) concentration increased (p<0.05) in 0.4 mg/ml YST1 and 0.2 mg/ml YST2 supplementation groups. Proportion of propionate, butyrate and valerate increased (p<0.05), but that of acetate decreased (p<0.05), which led to a decreased (p<0.05) acetate: propionate (A: P) ratio in the both YST2 treatments and the 0.4 mg/ml YST 1 supplementation groups. Hydrogen recovery decreased (p<0.05) with yeast supplementation. Quantity of methanogenic archaea per milliliter of inoculum decreased (p<0.05) with yeast supplementation after 24 h of incubation. Our results suggest that live yeast cells suppressed in vitro $CH_4$ production when inoculated into the large intestinal contents of pigs and shifted the fermentation pattern to favor propionate production together with an increased population of acetogenic bacteria, both of which serve as a competitive pathway for the available H2 resulting in the reduction of methanogenic archaea.